These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 22388835)
1. [Apheresis in the treatment of vasculitis]. Somenzi D; Corradini M; Pasquali S G Ital Nefrol; 2012; 29 Suppl 54():S73-7. PubMed ID: 22388835 [TBL] [Abstract][Full Text] [Related]
2. [The role of rituximab in the treatment of ANCA-associated systemic vasculitis]. Roccatello D; Vangelista A; Pani A G Ital Nefrol; 2011; 28(5):474-88. PubMed ID: 22028261 [TBL] [Abstract][Full Text] [Related]
3. Apheresis to treat systemic vasculitis. Moussi-Frances J; Sallée M; Jourde-Chiche N Joint Bone Spine; 2018 Mar; 85(2):177-183. PubMed ID: 28602810 [TBL] [Abstract][Full Text] [Related]
4. ANCA vasculitis: time for a change in treatment paradigm? Not yet. Ntatsaki E; Mooney J; Watts RA Rheumatology (Oxford); 2011 Jun; 50(6):1019-24. PubMed ID: 21292735 [TBL] [Abstract][Full Text] [Related]
5. Extracapillary glomerulonephritis type I with the coexistence of positive anti-GBM and p-ANCA antibodies. Toledo Perdomo K; Ortega Salas R; Pérez-Sáez MJ; Esquivias de Motta E; Espinosa Hernández M; López Andreu M; López Rubio F; Aljama García P Nefrologia; 2011; 31(1):113-5. PubMed ID: 21270926 [No Abstract] [Full Text] [Related]
6. Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: single-center results of stepwise escalation of immunosuppression. de Joode AA; Sanders JS; Smid WM; Stegeman CA J Clin Apher; 2014 Oct; 29(5):266-72. PubMed ID: 24497412 [TBL] [Abstract][Full Text] [Related]
7. [Rituximab for the treatment of ANCA associated vasculitis: the future today?]. Alba MA; Flores-Suárez LF Reumatol Clin; 2011 Dec; 7 Suppl 3():S41-6. PubMed ID: 22115869 [TBL] [Abstract][Full Text] [Related]